Skip to search formSkip to main contentSkip to account menu

Nonsteroidal Anti-Androgens

Known as: Anti-Androgens, Nonsteroidal, AntiAndrogens, Nonsteroidal, Nonsteroidal Anti Androgens 
Nonsteroidal agents which block the action or downregulate the synthesis of ANDROGENS.
National Institutes of Health

Related topics

Related topics

5 relations
In Bloodagonistsaspects of radiation effectschemical synthesis

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
A Second Act for Antiandrogens Men with advanced prostate cancer are often treated with antiandrogens; drugs that inhibit the… 
Highly Cited
2008
Highly Cited
2008
Alternative nonsteroidal antiandrogen therapy for advanced prostate cancer that relapsed after initial maximum androgen blockade.
Review
2005
Review
2005
Chemistry and structural biology of androgen receptor.
Androgen receptor (AR) is a member of the steroid and nuclear receptor superfamily,1 which is composed of over 100 members and… 
Highly Cited
2003
Highly Cited
2003
Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells.
PURPOSE Androgen deprivation is implicated in reducing neoangiogenesis in prostate cancer (PCA). Androgens regulate the… 
Highly Cited
2003
Highly Cited
2003
UV filters with antagonistic action at androgen receptors in the MDA-kb2 cell transcriptional-activation assay.
The fact that certain ultraviolet (UV) filters used in cosmetics display estrogenic activity prompted us to study potential… 
Review
2000
Review
2000
Single-Therapy Androgen Suppression in Men with Advanced Prostate Cancer
Androgen ablation delays clinical progression and palliates symptoms of metastatic disease in men with advanced prostate cancer… 
Highly Cited
1997
Highly Cited
1997
Preliminary results of a prospective randomized study comparing radical prostatectomy versus radical prostatectomy associated with neoadjuvant hormonal combination therapy in T2-3 N0 M0 prostatic…
Highly Cited
1997
Highly Cited
1997
Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.
Highly Cited
1995
Highly Cited
1995
Dramatic prostate specific antigen decrease in response to discontinuation of megestrol acetate in advanced prostate cancer: expansion of the antiandrogen withdrawal syndrome.
Highly Cited
1993
Highly Cited
1993
Mutant androgen receptor detected in an advanced-stage prostatic carcinoma is activated by adrenal androgens and progesterone.
Structural changes of the androgen receptor (AR) may contribute to the development of resistance to endocrine therapy in… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License